GSK3: a kinase balancing promotion and resolution of inflammation

L Hoffmeister, M Diekmann, K Brand, R Huber - Cells, 2020 - mdpi.com
GSK3 has been implicated for years in the regulation of inflammation and addressed in a
plethora of scientific reports using a variety of experimental (disease) models and …

Deception and Manipulation: The Arms of Leishmania, a Successful Parasite

P Cecílio, B Pérez-Cabezas, N Santarém… - Frontiers in …, 2014 - frontiersin.org
Leishmania spp. are intracellular parasitic protozoa responsible for a group of neglected
tropical diseases, endemic in 98 countries around the world, called leishmaniasis. These …

Innate immunity against Leishmania infections

P Gurung, TD Kanneganti - Cellular microbiology, 2015 - Wiley Online Library
Leishmaniasis is a major health problem that affects more than 300 million people
throughout the world. The morbidity associated with the disease causes serious economic …

Food-and vector-borne parasitic zoonoses: global burden and impacts

MS Hossain, T Hatta, SS Labony, KD Kwofie… - Advances in …, 2023 - Elsevier
Around 25% of the global population suffer from one or more parasitic infections, of which
food-and vector-borne parasitic zoonotic diseases are a major concern. Additionally …

Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors

P Gurung, TD Kanneganti - Cellular and Molecular Life Sciences, 2016 - Springer
Nod-like receptors (NLRs) have gained attention in recent years because of the ability of
some family members to assemble into a multimeric protein complex known as the …

Cytokines and signaling networks regulating disease outcomes in leishmaniasis

A Saha, S Roy, A Ukil - Infection and Immunity, 2022 - Am Soc Microbiol
Cytokines play crucial roles in commencing and coordinating the organized recruitment and
activation of immune cells during infection. These molecular regulators play an important …

The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice

DP Lage, VT Martins, DL Vale, CS Freitas, BL Pimenta… - Acta Tropica, 2023 - Elsevier
Abstract Treatment of visceral leishmaniasis (VL) is compromised by drug toxicity, high cost
and/or the emergence of resistant strains. Though canine vaccines are available, there are …

Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis

P Cecilio, B Pérez-Cabezas, L Fernández… - PLoS Neglected …, 2017 - journals.plos.org
The notion that previous infection by Leishmania spp. in endemic areas leads to robust anti-
Leishmania immunity, supports vaccination as a potentially effective approach to prevent …

The impact of IL-10 dynamic modulation on host immune response against visceral leishmaniasis

I Mesquita, C Ferreira, AM Barbosa, CM Ferreira… - Cytokine, 2018 - Elsevier
Leishmaniasis is a vector-borne disease caused by protozoan parasites from the genus
Leishmania. The most severe form of disease is visceral leishmaniasis (VL), which is fatal if …

Metabolic regulation of infection and inflammation

P Chauhan, B Saha - Cytokine, 2018 - Elsevier
Immunometabolic framework provides a way to understand the immune regulation via cell
intrinsic metabolic fluxes and metabolites during infections, tumors, and inflammatory …